Comments invited on how EMA consults Notified Bodies over combination ATMPs
This article was originally published in Clinica
Executive Summary
The European Medicines Agency yesterday released for external consultation a document laying out the basis for how the agency's Committee for Advanced Therapies (CAT) and Notified Bodies will interact when assessing combination Advanced Therapy Medicinal Products (ATMPs) which incorporate medical devices.